We want to let parents, caregivers, pediatricians and those involved in the care of children, know about the most recent Pediatric Vision Clinical Trial at Eye Physicians & Surgeons PC (EPS).
EPS is the only place in Connecticut for this clinical trial. The clinical trial is investigating which works better—glasses and then later patching or glasses with patching at the same time? The clinical trial is part of a collaborative national network of pediatric ophthalmologists and optometrists called PEDIG (Pediatric Eye Disease Investigator Group) started in 1997. See link at www.public.jaeb.org
This study is for children between the ages of 3 to under 13 years old. Most of the time, your child will have a failed vision screening and that is how we will know if he or she could qualify for the study. The study is sponsored by the National Institutes of Health-National Eye Institute www.nei.nih.gov
Here is the official name of the study:
Amblyopia Treatment Study 22: A Randomized Trial to Evaluate Sequential versus Simultaneous Spectacles plus Patching.
The investigator at EPS is Dr. Jennifer A. Galvin.
Why the number 22? Because it is the 22nd study about amblyopia at PEDIG. What is amblyopia? Amblyopia is the most common cause of decreased vision in children.
We are able to see qualifying children for the clinical trial at all of our five offices. No previous treatment of amblyopia, including glasses or contact lenses is allowed. Vision in the amblyopic eye must be between 20/40 and 20/200. Other points of the study are about improving depth perception and asking about child and parental quality of life perspective.
If you have any questions about the study or the treatment of amblyopia, contact Dr. Galvin at our office.
Blog post by Jennifer A. Galvin, MD, a Board-Certified ophthalmologist with fellowship training in pediatric ophthalmology and adult strabismus at Eye Physicians & Surgeons PC. Call Eye Physicians & Surgeons PC at (203) 878-1236 to make an appointment today.
